Bioregenx (BRGX) Return on Sales (2022 - 2026)

Bioregenx's Return on Sales history runs 5 years deep, the most recent figure standing at 0.0% for Q1 2026.

• In Q1 2026, Return on Sales changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.01% (up 8.0% YoY), while the FY2025 annual figure was 0.01%, up 9.0% from the prior year.
• Return on Sales was 0.0% for Q1 2026 at Bioregenx, up from 0.03% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q3 2023 to a low of 0.4% in Q4 2024.
• Historically, Return on Sales has averaged 0.03% across 5 years, with a median of 0.01% in 2022.
• The sharpest annual moves came in 2024 and 2025: Return on Sales sank 39 bps in 2024, then soared 37 bps in 2025.
• A 5-year view of Return on Sales shows it stood at 0.01% in 2022, then plunged by 71 bps to 0.01% in 2023, then tumbled by 3663 bps to 0.4% in 2024, then soared by 93 bps to 0.03% in 2025, then surged by 89 bps to 0.0% in 2026.
• The last three Return on Sales figures came in at 0.0% (Q1 2026), 0.03% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.